Xing Yuan Selected Research

bacopaside I

5/2016	Erratum: Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid.
3/2016	Bacopaside I ameliorates cognitive impairment in APP/PS1 mice via immune-mediated clearance of β-amyloid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xing Yuan Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 11/2002
7	Hepatocellular Carcinoma (Hepatoma) 04/2018 - 11/2013
5	Tuberculosis (Tuberculoses) 11/2019 - 07/2014
4	Infections 11/2019 - 03/2010
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2020
3	Wounds and Injuries (Trauma) 01/2018 - 07/2007
2	Ischemic Stroke 03/2018 - 05/2012
2	Brain Ischemia (Cerebral Ischemia) 03/2018 - 05/2012
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2018 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2018 - 10/2014
2	Extensively Drug-Resistant Tuberculosis 01/2017 - 01/2017
2	Cognitive Dysfunction 05/2016 - 03/2016
2	Pheochromocytoma 03/2015 - 05/2012
2	Carcinoma (Carcinomatosis) 10/2014 - 04/2014
1	Pain (Aches) 09/2022
1	Ulcerative Colitis 09/2022
1	Drug Resistant Epilepsy 01/2022
1	Dysbiosis 01/2021
1	Exanthema (Rash) 09/2020
1	Pruritus (Itching) 09/2020
1	Hand-Foot Syndrome 09/2020
1	Ascites 01/2020
1	Atrophy 11/2019
1	Extrapulmonary Tuberculosis 11/2019
1	Body Weight (Weight, Body) 11/2019
1	Proteinuria 11/2019
1	Inflammation (Inflammations) 01/2019
1	Headache (Headaches) 01/2019
1	Cough 01/2019
1	Purpura 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Epilepsy (Aura) 01/2019
1	Liver Neoplasms (Liver Cancer) 04/2018
1	Brain Edema (Cerebral Edema) 03/2018
1	Brain Infarction 03/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Myocardial Infarction 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Arthritis (Polyarthritis) 01/2017
1	Experimental Arthritis 01/2017
1	Necrosis 01/2017

Drug/Important Bio-Agent (IBA)

6	Biological ProductsIBA 04/2018 - 04/2009
5	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2018
4	Pharmaceutical PreparationsIBA 01/2017 - 07/2014
3	CytokinesIBA 09/2022 - 07/2014
3	LipidsIBA 11/2019 - 11/2002
3	CateninsIBA 01/2018 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2007
2	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2020
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2019
2	SantoninIBA 04/2018 - 01/2017
2	GuanineIBA 04/2018 - 12/2016
2	XanthineIBA 04/2018 - 12/2016
2	Therapeutic UsesIBA 10/2017 - 03/2016
2	FluoroquinolonesIBA 01/2017 - 01/2017
2	Isoniazid (Ftivazide)FDA LinkGeneric 01/2017 - 01/2017
2	Amikacin (A.M.K)FDA LinkGeneric 01/2017 - 01/2017
2	Kanamycin FDA Link 01/2017 - 01/2017
2	bacopaside IIBA 05/2016 - 03/2016
2	Amyloid (Amyloid Fibrils)IBA 05/2016 - 03/2016
2	Neuroprotective AgentsIBA 03/2016 - 05/2012
2	OligodeoxyribonucleotidesIBA 03/2004 - 11/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2004 - 11/2002
1	glycyrrhizae radix et rhizomaIBA 09/2022
1	Mitochondrial DNA (mtDNA)IBA 09/2022
1	cupric sulfide (CuS)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2020
1	apatinibIBA 09/2020
1	pembrolizumabIBA 09/2020
1	NivolumabIBA 09/2020
1	Alanine Transaminase (SGPT)IBA 09/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	bilobetinIBA 11/2019
1	Inflammation MediatorsIBA 11/2019
1	purineIBA 01/2019
1	NucleotidesIBA 01/2019
1	Ionotropic Glutamate ReceptorsIBA 03/2018
1	perampanelIBA 03/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2018
1	STA 9090IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	tanespimycin (17AAG)IBA 01/2018
1	nitazoxanide (NTZ)FDA Link 01/2018
1	bruceine DIBA 10/2017
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	AminoglycosidesIBA 01/2017
1	Ubiquitin-Conjugating EnzymesIBA 01/2017
1	Moxifloxacin (Avelox)FDA Link 01/2017

Therapy/Procedure

3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022 - 03/2015
3	Therapeutics 01/2022 - 07/2014
3	Drug Therapy (Chemotherapy) 05/2021 - 07/2014
1	Vagus Nerve Stimulation 01/2022
1	Immunotherapy 01/2022
1	Neoadjuvant Therapy 05/2021
1	Intraperitoneal Injections 11/2019
1	Oral Administration 03/2018
1	Injections 01/2017